{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:42:49Z","timestamp":1787503369870,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVES:<\/jats:title>\n                    <jats:p>Opioids are used to manage pain, comfort, maintain devices, and decrease oxygen consumption around Norwood palliation (NP), but in high dose and prolonged exposure, they increase risk of tolerance and iatrogenic withdrawal syndrome (IAWS). Variability in practice for IAWS prevention potentially increases opioid dose and duration. We hypothesize that protocolized weaning with morphine (MOR) versus nonprotocolized methadone (MTD) is associated with reduction in opioid exposure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DESIGN:<\/jats:title>\n                    <jats:p>A before-versus-after study of outcomes of patients weaned with protocolized MOR versus nonprotocolized MTD including subset analysis for those patients with complications postoperatively. Primary endpoints include daily, wean phase, and total morphine milligram equivalent (MMEq) dose, duration, and, secondarily, length of stay (LOS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SETTING:<\/jats:title>\n                    <jats:p>Quaternary-care pediatric cardiac ICU.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PATIENTS:<\/jats:title>\n                    <jats:p>Neonates undergoing single-ventricle palliation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>INTERVENTIONS:<\/jats:title>\n                    <jats:p>Introduction of IAWS prevention protocol.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n                    <jats:p>\n                      Analysis included 54 patients who underwent the NP in 2017\u20132018 including the subset analysis of 34 who had a complicated postoperative course. The total and wean phase opioid doses for the MTD group were significantly higher than that for the MOR group: 258 versus 22 and 115 versus 6 MMEq\/kg;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001. Duration of opioid exposure was 63 days in the MTD group and 12 days in MOR group (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001). Subanalysis of the complicated subset also identifies higher total and wean dose for MTD group (293 vs 41 and 116 vs 7 MMEq\/kg;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001) with a longer duration (65 vs 22 days;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.001). Within the subset, LOS was 55% longer in the MTD group than that in the MOR group (150 vs 67 d;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.01) and not different in the uncomplicated group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>After complex NP, a protocolized opioid weaning using MOR versus MTD is associated with 65% shorter opioid duration, 10-fold decreased dose, and shortened LOS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/pcc.0000000000002885","type":"journal-article","created":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T13:53:24Z","timestamp":1641304404000},"page":"361-370","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Opioid Weaning Protocol Using Morphine Compared With Nonprotocolized Methadone Associated With Decreased Dose and Duration of Opioid After Norwood Procedure"],"prefix":"10.1097","volume":"23","author":[{"given":"Barbara-Jo","family":"Achuff","sequence":"first","affiliation":[{"name":"Pediatric Critical Care, Baylor College of Medicine, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Lemming","sequence":"additional","affiliation":[{"name":"Pediatric Critical Care, Baylor College of Medicine, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie C.","family":"Causey","sequence":"additional","affiliation":[{"name":"Pediatric Critical Care, Baylor College of Medicine, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry A.","family":"Sembera","sequence":"additional","affiliation":[{"name":"Pharmacy, Texas Children\u2019s Hospital, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Checchia","sequence":"additional","affiliation":[{"name":"Pediatric Critical Care, Baylor College of Medicine, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Heinle","sequence":"additional","affiliation":[{"name":"Pediatric Critical Care, Baylor College of Medicine, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy S.","family":"Ghanayem","sequence":"additional","affiliation":[{"name":"Nursing, Texas Children's Hospital, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,1,5]]},"reference":[{"key":"R1-20250502","first-page":"96","article-title":"Reestablishing health: Factors influencing the child\u2019s recovery in pediatric intensive care.","volume":"4","author":"Kidder","year":"1989","journal-title":"J Pediatr Nurs"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.atc.2004.11.008","article-title":"Postoperative pain management in children.","volume":"23","author":"Verghese","year":"2005","journal-title":"Anesthesiol Clin North Am"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0022-3476(05)82420-5","article-title":"Reversible neurologic abnormalities associated with prolonged intravenous midazolam and fentanyl administration.","volume":"119","author":"Bergman","year":"1991","journal-title":"J Pediatr"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0022-3476(05)82421-7","article-title":"Movement disorder after withdrawal of fentanyl infusion.","volume":"119","author":"Lane","year":"1991","journal-title":"J Pediatr"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4037\/ajcc1998.7.5.364","article-title":"Opioid withdrawal in neonates after continuous infusions of morphine or fentanyl during extracorporeal membrane oxygenation.","volume":"7","author":"Franck","year":"1998","journal-title":"Am J Crit Care"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1460-9592.2001.00764.x","article-title":"Opioid tolerance in neonates: A state-of-the-art review.","volume":"11","author":"Suresh","year":"2001","journal-title":"Paediatr Anaesth"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"e1208","DOI":"10.1542\/peds.2009-0489","article-title":"Tolerance and withdrawal from prolonged opioid use in critically ill children.","volume":"125","author":"Anand","year":"2010","journal-title":"Pediatrics"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/PCC.0000000000000306","article-title":"Risk factors associated with iatrogenic opioid and benzodiazepine withdrawal in critically ill pediatric patients: A systematic review and conceptual model.","volume":"16","author":"Best","year":"2015","journal-title":"Pediatr Crit Care Med"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1097\/CCM.0b013e318181600d","article-title":"Withdrawal symptoms in critically ill children after long-term administration of sedatives and\/or analgesics: A first evaluation.","volume":"36","author":"Ista","year":"2008","journal-title":"Crit Care Med"},{"key":"R10-20250502","first-page":"CD002052","article-title":"Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit.","volume":"6","author":"Ng","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/j.1460-9592.2011.03581.x","article-title":"Neurodevelopmental outcome following exposure to sedative and analgesic drugs for complex cardiac surgery in infancy.","volume":"21","author":"Guerra","year":"2011","journal-title":"Paediatr Anaesth"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/pan.12257","article-title":"Neurotoxicity of sedative and analgesia drugs in young infants with congenital heart disease: 4-year follow-up.","volume":"24","author":"Garcia Guerra","year":"2014","journal-title":"Paediatr Anaesth"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1097\/00003246-200006000-00079","article-title":"Tolerance, withdrawal, and physical dependency after long-term sedation and analgesia of children in the pediatric intensive care unit.","volume":"28","author":"Tobias","year":"2000","journal-title":"Crit Care Med"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jcrc.2017.08.049","article-title":"Implementation of a risk-stratified opioid weaning protocol in a pediatric intensive care unit.","volume":"43","author":"Sanchez-Pinto","year":"2018","journal-title":"J Crit Care"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1097\/PCC.0000000000001719","article-title":"Implementation of a risk-stratified opioid and benzodiazepine weaning protocol in a pediatric cardiac ICU.","volume":"19","author":"Amirnovin","year":"2018","journal-title":"Pediatr Crit Care Med"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s40265-020-01338-4","article-title":"Strategies for the prevention and treatment of iatrogenic withdrawal from opioids and benzodiazepines in critically ill neonates, children and adults: A systematic review of clinical studies.","volume":"80","author":"Sneyers","year":"2020","journal-title":"Drugs"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/pan.13056","article-title":"The use of methadone to facilitate opioid weaning in pediatric critical care patients: A systematic review of the literature and meta-analysis.","volume":"27","author":"Dervan","year":"2017","journal-title":"Pediatr Anesth"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"2333794X17721128","DOI":"10.1177\/2333794X17721128","article-title":"Morphine versus methadone treatment for neonatal withdrawal and impact on early infant development.","volume":"4","author":"Burke","year":"2017","journal-title":"Glob Pediatr Health"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/01.PCC.0000200955.40962.38","article-title":"State Behavioral Scale (SBS) a sedation assessment instrument for infants and young children supported on mechanical ventilation.","volume":"7","author":"Curley","year":"2006","journal-title":"Pediatr Crit Care Med"},{"key":"R21-20250502","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/PCC.0b013e31818c8328","article-title":"The Withdrawal Assessment Tool-Version 1 (WAT-1): An assessment instrument for monitoring opioid and benzodiazepine withdrawal symptoms in pediatric patients.","volume":"9","author":"Franck","year":"2008","journal-title":"Pediatr Crit Care Med"},{"key":"R22-20250502","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/ADM.0000000000000197","article-title":"Opioid and benzodiazepine withdrawal syndrome in PICU patients: Which risk factors matter?","volume":"10","author":"da Silva","year":"2016","journal-title":"J Addict Med"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1089\/jpm.1999.2.209","article-title":"Opioid equianalgesic calculations.","volume":"2","author":"Gordon","year":"1999","journal-title":"J Palliat Med"},{"key":"R24-20250502","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3390\/brainsci4020295","article-title":"Anesthesia and the developing brain: Relevance to the pediatric cardiac surgery.","volume":"4","author":"Wise-Faberowski","year":"2014","journal-title":"Brain Sci"},{"key":"R25-20250502","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/pan.12350","article-title":"The association between brain injury, perioperative anesthetic exposure, and 12-month neurodevelopmental outcomes after neonatal cardiac surgery: A retrospective cohort study.","volume":"24","author":"Andropoulos","year":"2014","journal-title":"Paediatr Anaesth"},{"key":"R26-20250502","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jama.2014.18399","article-title":"Protocolized sedation vs usual care in pediatric patients mechanically ventilated for acute respiratory failure: A randomized clinical trial.","volume":"313","author":"Curley","year":"2015","journal-title":"JAMA"},{"key":"R27-20250502","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1542\/peds.98.1.135","article-title":"The management of opioid and benzodiazepine dependence in infants, children, and adolescents.","volume":"98","author":"Yaster","year":"1996","journal-title":"Pediatrics"},{"key":"R28-20250502","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1213\/01.ane.0000202395.94542.3e","article-title":"A prospective evaluation of opioid weaning in opioid-dependent pediatric critical care patients.","volume":"102","author":"Berens","year":"2006","journal-title":"Anesth Analg"},{"key":"R30-20250502","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0885-3924(01)00271-8","article-title":"Accuracy in equianalgesic dosing. conversion dilemmas.","volume":"21","author":"Anderson","year":"2001","journal-title":"J Pain Symptom Manage"},{"key":"R31-20250502","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2165\/00003088-199631060-00003","article-title":"Clinical pharmacokinetics of sedatives in neonates.","volume":"31","author":"Jacqz-Aigrain","year":"1996","journal-title":"Clin Pharmacokinet"},{"issue":"8 Suppl 1","key":"R32-20250502","doi-asserted-by":"crossref","first-page":"S232","DOI":"10.1097\/PCC.0000000000000800","article-title":"Neurodevelopmental outcomes in children with congenital heart disease\u2013what can we impact?","volume":"17","author":"Wernovsky","year":"2016","journal-title":"Pediatric Crit Care Med"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000002885","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T13:28:59Z","timestamp":1746192539000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000002885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000002885","relation":{},"ISSN":["1529-7535"],"issn-type":[{"value":"1529-7535","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,5]]}}}